This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Bio-Techne Corporation. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: The Innovations of Ernesto Ruben Resnik
Introduction
Ernesto Ruben Resnik is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has advanced the understanding and application of these important biological tools.
Latest Patents
Resnik's latest patents include innovations related to hybridoma clones and monoclonal antibodies targeting VSIG-4. These patents describe monoclonal antibodies that bind to VSIG-4, including those that block the binding of VSIG-4 to SIGLEC-7. The patents also cover compositions that include these monoclonal antibodies, as well as methods for making and using them.
Career Highlights
Resnik is currently associated with Bio-Techne Corporation, where he continues to push the boundaries of biotechnological research. His work has been instrumental in developing new therapeutic approaches that leverage the power of monoclonal antibodies.
Collaborations
Some of his notable coworkers include Birte Aggeler and Christine Goetz, who have collaborated with him on various projects within the biotechnology sector.
Conclusion
Ernesto Ruben Resnik's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of innovative therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile